Treatment with colchicine decreases white cell counts in synovial fluid of asymptomatic knees that contain monosodium urate crystals
- PMID: 1593582
Treatment with colchicine decreases white cell counts in synovial fluid of asymptomatic knees that contain monosodium urate crystals
Abstract
Synovial fluid (SF) samples, all containing monosodium urate crystals, obtained from 18 asymptomatic knees of 12 patients with gout, were serially analyzed before and one month after treatment with 1 mg/day of oral colchicine. Before treatment, the SF contained 612 [confidence limits (CL) = 282, 942] cells/mm3, while after treatment these values decreased to 274 (CL = 73, 471) cells/mm3 (p less than 0.005). In all cases, pretreatment cell counts were higher than the corresponding posttreatment values. The percentage of polymorphonuclear leukocytes also diminished from a pretreatment value of 13.0 (CL = 7, 19) to 4.5 (CL = 2, 7) after colchicine administration (p less than 0.005). These results strongly suggest the presence of baseline subclinical joint inflammation which is reduced by colchicine. The preventive effect of this drug on the occurrence of new attacks may relate to its effect in reducing the baseline inflammation of the asymptomatic joints.
Similar articles
-
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?J Rheumatol. 2001 Mar;28(3):577-80. J Rheumatol. 2001. PMID: 11296962 Clinical Trial.
-
Monosodium urate crystals in asymptomatic knee joints.J Rheumatol. 1982 Nov-Dec;9(6):967-9. J Rheumatol. 1982. PMID: 7161792
-
Prospective study of morphology and phagocytosis of synovial fluid monosodium urate crystals in gouty arthritis.J Rheumatol. 1984 Dec;11(6):741-4. J Rheumatol. 1984. PMID: 6520827
-
Joint aspiration and injection and synovial fluid analysis.Best Pract Res Clin Rheumatol. 2009 Apr;23(2):161-92. doi: 10.1016/j.berh.2009.01.003. Best Pract Res Clin Rheumatol. 2009. PMID: 19393565 Review.
-
Pathogenesis, clinical findings and management of acute and chronic gout.Minerva Med. 2006 Dec;97(6):495-509. Minerva Med. 2006. PMID: 17213786 Review.
Cited by
-
Oral colchicine (Colcrys): in the treatment and prophylaxis of gout.Drugs. 2010 Aug 20;70(12):1603-13. doi: 10.2165/11205470-000000000-00000. Drugs. 2010. PMID: 20687623 Review.
-
Gout Is Prevalent but Under-Registered Among Patients With Cardiovascular Events: A Field Study.Front Med (Lausanne). 2020 Sep 29;7:560. doi: 10.3389/fmed.2020.00560. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33117824 Free PMC article.
-
Managing Gout in the Patient with Renal Impairment.Drugs Aging. 2018 Apr;35(4):263-273. doi: 10.1007/s40266-018-0517-7. Drugs Aging. 2018. PMID: 29435850 Review.
-
Gout: optimizing treatment to achieve a disease cure.Ther Adv Chronic Dis. 2016 Mar;7(2):135-44. doi: 10.1177/2040622315618393. Epub 2016 Jan 12. Ther Adv Chronic Dis. 2016. PMID: 26977282 Free PMC article. Review.
-
Sonographic Tophi and Inflammation Are Associated With Carotid Atheroma Plaques in Gout.Front Med (Lausanne). 2021 Dec 16;8:795984. doi: 10.3389/fmed.2021.795984. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34977097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical